Latest Breaking News On - Dimitrios skaltsas - Page 1 : vimarsana.com

Intelligencia AI Awarded U S Patent for Its Accurate and Transparent Probability of Drug

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) Intelligencia AI, a provider of AI-powered solutions that support data-driven decision-making in drug development, today announced that the U.S. Patent and Trademark

New yorkUnited statesSan franciscoDimitrios skaltsasTrademark officeInteracting with clinical dataIntelligencia portfolio optimizer

Intelligencia AI Awarded U S Patent for Its Accurate and Transparent Probability of Drug Success Assessments

Intelligencia AI Awarded U S Patent for Its Accurate and Transparent Probability of Drug Success Assessments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesNew yorkDimitrios skaltsasAlexandra ferraroTrademark officeInteracting with clinical dataIntelligencia portfolio optimizer

Intelligencia AI Awarded U S Patent for Its Accurate and

Health tech company pioneers de-risking clinical development through patented algorithms, technology and use of artificial intelligence .

New yorkUnited statesSan franciscoDimitrios skaltsasTrademark officeInteracting with clinical dataPortfolio optimizerAi in drug developmentRobability of successClinical developmentArtificial intelligencePharmaceutical industry

Health Tech Company Intelligencia AI Appoints Scientific Advisory Board Chair

NEW YORK (BUSINESS WIRE) Nov 6, 2023

New yorkUnited statesSan franciscoDimitrios skaltsasAlexandra ferraroAnalytics programInformation sciences at astrazenecaScientific advisory boardScientific advisorySenior vice presidentInformation sciencesEnterprise dataIntelligencia portfolio optimizerBusiness wire

Global AI in Clinical Trials Market Overview 2023-2035: AI

Dublin, Aug. 18, 2023 (GLOBE NEWSWIRE) The "AI in Clinical Trials Market: Software and Service Providers - Distribution by Trial Phase, Target.

New yorkUnited statesUnited kingdomMemorial sloan kettering cancer centerAl iskandariyahCancer instituteAl qahirahInvestissement quebecMichael shiptonSingtel innovAsahi kaseiDimitrios skaltsasTroy bryentonKleiner perkinsDanielle ralicDarcy forman